What is the recommended treatment for a patient with a normal immune system and no contraindications experiencing a herpes simplex or herpes zoster breakout?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Herpes Breakout

For immunocompetent patients with herpes simplex, use oral acyclovir 200 mg five times daily for 7-10 days for initial episodes, or 200-800 mg orally for 5 days for recurrent episodes; for herpes zoster, use valacyclovir 1 gram three times daily for 7 days or acyclovir 800 mg five times daily for 7-10 days, initiated within 72 hours of rash onset. 1, 2, 3, 4, 5

Herpes Simplex Treatment Algorithm

First Clinical Episode (Genital or Orolabial)

  • Acyclovir 200 mg orally 5 times daily for 7-10 days until clinical resolution 1
  • For herpes proctitis specifically: Acyclovir 400 mg orally 5 times daily for 10 days 1
  • Therapy is most effective when started within 48 hours of symptom onset 1, 4

Recurrent Episodes

  • Acyclovir 200 mg orally 5 times daily for 5 days, OR 1
  • Acyclovir 400 mg orally 3 times daily for 5 days, OR 1
  • Acyclovir 800 mg orally 2 times daily for 5 days 1
  • Treatment provides limited benefit unless initiated during prodrome or within 2 days of lesion onset 1
  • Most immunocompetent patients with recurrent disease do not benefit significantly from treatment 1

Cold Sores (Herpes Labialis)

  • Valacyclovir 2 grams twice daily for 1 day (12 hours apart) 4
  • Initiate at earliest symptom (tingling, itching, burning) 4

Suppressive Therapy (for frequent recurrences ≥6 per year)

  • Acyclovir 400 mg orally twice daily 1
  • Alternative: Acyclovir 200 mg orally 3-5 times daily 1
  • Reduces recurrence frequency by at least 75% 1
  • After 1 year of continuous therapy, discontinue to reassess recurrence rate 1

Herpes Zoster (Shingles) Treatment Algorithm

Uncomplicated Herpes Zoster

  • First-line: Valacyclovir 1 gram orally three times daily for 7 days 2, 3, 4
  • Alternative: Acyclovir 800 mg orally 5 times daily for 7-10 days 1, 2, 3, 5
  • Alternative: Famciclovir 500 mg orally three times daily for 7 days 2, 3
  • Critical timing: Initiate within 72 hours of rash onset for optimal efficacy in reducing acute pain and preventing postherpetic neuralgia 2, 3, 4
  • Treatment is most effective when started within 48 hours 2, 5
  • Continue treatment until all lesions have completely scabbed, not just for an arbitrary 7-day period 2, 3

Disseminated or Invasive Herpes Zoster

  • Intravenous acyclovir 5-10 mg/kg every 8 hours 2, 3
  • Continue for minimum 7-10 days and until clinical resolution 2, 3
  • Consider temporary reduction in immunosuppressive medications if applicable 2, 3
  • Switch to oral therapy once clinical improvement occurs 3

Critical Treatment Considerations

Topical Therapy

Topical acyclovir is substantially less effective than oral therapy and its use is discouraged for both herpes simplex and herpes zoster 1, 2

Severe Disease Requiring Hospitalization

  • Intravenous acyclovir 5-10 mg/kg every 8 hours for 5-7 days until clinical resolution 1
  • Indications: disseminated infection, encephalitis, pneumonitis, hepatitis, multi-dermatomal involvement, CNS complications, or complicated ocular disease 1, 2, 3

Acyclovir-Resistant Cases

  • Foscarnet 40 mg/kg IV every 8 hours until clinical resolution 2, 3, 6
  • Resistance is extremely rare in immunocompetent patients but occurs more frequently in immunocompromised patients on prolonged suppressive therapy 1, 2
  • All acyclovir-resistant strains are also resistant to valacyclovir, and most to famciclovir 2
  • Topical cidofovir gel 1% applied once daily for 5 consecutive days may be an alternative 2

Common Pitfalls and Caveats

Timing Errors

  • Do not delay treatment beyond 72 hours for herpes zoster—efficacy decreases significantly 2, 3, 4
  • For herpes simplex recurrences, treatment after 2 days of lesion onset provides minimal benefit 1

Duration Errors

  • Do not stop treatment at exactly 7 days if lesions are still forming or have not completely scabbed—continue until all lesions have crusted 2, 3
  • Immunocompromised patients may require extended treatment beyond 7-10 days as lesions develop over longer periods (7-14 days) and heal more slowly 2

Dosing Errors

  • Do not use genital herpes dosing (400 mg TDS) for herpes zoster—this is inadequate for VZV infection 2
  • Herpes zoster requires higher doses: acyclovir 800 mg five times daily or valacyclovir 1 gram three times daily 2, 3, 4

Renal Function Monitoring

  • Monitor renal function closely during IV acyclovir therapy with dose adjustments for renal impairment 2, 4, 5
  • Valacyclovir and famciclovir require dose adjustments in renal impairment 2, 3

Infection Control

  • Patients should avoid contact with susceptible individuals until all lesions have crusted, as lesions are contagious to those who have not had chickenpox or vaccination 2
  • Advise abstaining from sexual activity while herpes simplex lesions are present 1

Post-Treatment Prevention

  • Recombinant zoster vaccine (Shingrix) is recommended for all adults ≥50 years, regardless of prior herpes zoster episodes, to prevent future recurrences 2, 3
  • Vaccination should ideally occur before initiating immunosuppressive therapies 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.